Adenovirus-based Solutions for Environmental Remediation and Sustainability
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of the original patent to develop novel applications in environmental remediation, industrial processes, and agricultural sustainability, utilizing replication-defective adenovirus-based systems to enhance microorganism-mediated pollutant degradation, water quality monitoring, and crop yield improvement.
Background and Problem Solved
The original patent focused on inducing immunity against SARS-CoV-2 using spike (S) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus. However, this technology has broader potential beyond vaccine development. The inventive concept addresses the limitations of current environmental remediation methods, industrial processes, and agricultural practices, which often rely on inefficient or unsustainable approaches. By applying the adenovirus-based technology to these new fields, we can develop more effective and eco-friendly solutions.
Detailed Description of the Inventive Concept
The new claims describe adenovirus-based systems for treating wastewater, reducing pollutants in industrial processes, bioremediation, monitoring water quality, and improving crop yields. These systems utilize replication-defective adenoviruses encoding spike protein sequences optimized for cell surface expression and nucleocapsid proteins fused to endosomal targeting sequences. The adenoviruses are used to express these proteins in microorganisms, enhancing their ability to degrade pollutants, fix nitrogen, and promote plant growth. The inventive concept enables the development of more efficient and sustainable environmental remediation methods, industrial processes, and agricultural practices.
Novelty and Inventive Step
The novelty of this inventive concept lies in the application of adenovirus-based technology to entirely new fields, leveraging the original patent's core technology to address distinct problems. The inventive step is the recognition of the potential for adenovirus-mediated protein expression in microorganisms to drive sustainable solutions in environmental remediation, industrial processes, and agriculture.
Alternative Embodiments and Variations
Alternative embodiments of this inventive concept could include the use of different adenovirus serotypes, varying the spike protein sequence or nucleocapsid protein fusion, or incorporating additional genes to further enhance microorganism-mediated pollutant degradation or plant growth promotion. Variations could also involve the development of adenovirus-based systems for other environmental or industrial applications, such as bioremediation of contaminated soil or groundwater.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the environmental remediation, industrial processes, and agricultural sectors. The market for sustainable solutions in these areas is growing rapidly, driven by increasing concerns about environmental degradation, climate change, and food security. Adenovirus-based systems could provide a competitive advantage in these markets, offering more efficient, eco-friendly, and cost-effective solutions for wastewater treatment, pollutant reduction, bioremediation, and crop yield improvement.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K39/215 |
| A | A61 | A61K39/39 |
| C | C12 | C12N15/86 |
| A | A61 | A61K2039/545 |
| A | A61 | A61K2039/55505 |
| A | A61 | A61P31/14 |
| C | C12 | C12N2710/10343 |
| C | C12 | C12N2770/20022 |
| C | C12 | C12N2770/20034 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biotechnology and molecular virology, with expertise in viral vector design, protein engineering, and genetic modification of microorganisms for therapeutic, environmental, and agricultural applications
Person of Ordinary Skill (PHOSITA) Profile
A skilled researcher with advanced degrees in molecular biology, virology, or bioengineering, possessing knowledge of adenovirus vector systems, protein expression techniques, and interdisciplinary applications of genetic engineering
Obviousness Rationale
The PTD represents a predictable extension of the source patent's core adenovirus-based protein expression technology by applying the fundamental viral vector design to novel environmental and agricultural contexts. A PHOSITA would recognize the inherent versatility of replication-defective adenovirus systems for protein delivery and expression across different biological domains. The technical principles of spike and nucleocapsid protein manipulation demonstrated in the original SARS-CoV-2 vaccine context directly translate to other protein expression and cellular modification applications.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,620 |
|---|---|
| Title | Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus |
| Assignee(s) | ImmunityBio, Inc. |